143 related articles for article (PubMed ID: 38774762)
1. Haploidentical hematopoietic stem cell transplantation as a first-line treatment for paediatric severe aplastic anemia: a single-center research.
Yuan M; Jia C; Ma J; Zhang M; Zhu G; Wang B; Zheng J; Qin M; Wu R; Li S
Int J Med Sci; 2024; 21(6):1027-1036. PubMed ID: 38774762
[TBL] [Abstract][Full Text] [Related]
2. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study.
Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H
Front Immunol; 2024; 15():1384640. PubMed ID: 38720904
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor.
Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z
Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223
[TBL] [Abstract][Full Text] [Related]
4. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
Geng C; Liu X; Chen M; Yang C; Han B
Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia.
Liu L; Zhang Y; Jiao W; Zhou H; Wang Q; Jin S; Cai Y; Zhao L; Shangguan X; Liu Z; Xu J; Lei M; Yan X; Miao M; Wu D
Leukemia; 2020 Dec; 34(12):3359-3369. PubMed ID: 32591644
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation without in vivo T-cell depletion for pediatric aplastic anemia: A single-center experience.
Li S; Wang B; Fu L; Pang Y; Zhu G; Zhou X; Ma J; Su Y; Qin M; Wu R
Pediatr Transplant; 2018 Aug; 22(5):e13204. PubMed ID: 29744996
[TBL] [Abstract][Full Text] [Related]
7. Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study.
Liu L; Lei M; Fu R; Han B; Zhao X; Liu R; Zhang Y; Jiao W; Miao M; Zhang F; Zhang L; Wu D
J Hematol Oncol; 2022 Aug; 15(1):105. PubMed ID: 35962406
[TBL] [Abstract][Full Text] [Related]
8. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350
[TBL] [Abstract][Full Text] [Related]
9. The role of donor type and pre-transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia.
Kashif R; Horn B; Milner J; Joyce M; Dalal M; Lee JJ; McNerney K; Cline J; Fort J; Castillo P; Galvez J; Alperstein W; Ligon J; Ziga E; Crawford D; Chellapandian D
Pediatr Transplant; 2024 Jun; 28(4):e14784. PubMed ID: 38766976
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia.
Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S
Front Immunol; 2022; 13():837335. PubMed ID: 35178053
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia.
Zhao J; Ma L; Zheng M; Su L; Guo X
Ann Hematol; 2023 Sep; 102(9):2565-2587. PubMed ID: 37442821
[TBL] [Abstract][Full Text] [Related]
12. Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?
Huang LF; Li L; Jia JS; Yang Y; Lin SY; Meng FK; Zhang DH; He GS
Transplant Cell Ther; 2022 Sep; 28(9):586.e1-586.e7. PubMed ID: 35609866
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia.
Xu ZL; Zhou M; Jia JS; Mo WJ; Zhang XH; Zhang YP; Wang Y; Li YM; Huang XJ; Wang SQ; Xu LP
Bone Marrow Transplant; 2019 Aug; 54(8):1319-1326. PubMed ID: 30670825
[TBL] [Abstract][Full Text] [Related]
14. Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review.
Yang Y; Ji J; Tang Z; Han B
Front Oncol; 2021; 11():614965. PubMed ID: 33981596
[No Abstract] [Full Text] [Related]
15. [Comparison of Frontline Haploidentical Hematopoietic Stem Cell Transplantation and Salvage Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia].
Xiao F; Liu Q; Fan D; Guo HX; Yan XQ; Zhao H; Liu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1683-1688. PubMed ID: 33067974
[TBL] [Abstract][Full Text] [Related]
16. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia.
Onishi Y; Mori T; Yamazaki H; Hiramoto N; Zaimoku Y; Kanaya M; Matsue K; Onizuka M; Aotsuka N; Uchida N; Onodera K; Kanda J; Nakamae H; Yamamoto R; Kuriyama T; Kimura T; Ichinohe T; Atsuta Y;
Transplant Cell Ther; 2023 Dec; 29(12):766.e1-766.e8. PubMed ID: 37730121
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of allogeneic hematopoietic stem cell transplantation in the treatment of 28 patients with hepatitis-related aplastic anemia].
Wang Y; Li J; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ
Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):628-634. PubMed ID: 37803835
[No Abstract] [Full Text] [Related]
19. First-line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy.
Cheng Y; Xu Z; Zhang Y; Wu J; Wang F; Mo X; Chen Y; Han W; Jia J; Wang Y; Zhang X; Huang X; Zhang L; Xu L
Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29297952
[TBL] [Abstract][Full Text] [Related]
20. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results.
Liu Z; Zhang Y; Xiao H; Yao Z; Zhang H; Liu Q; Wu B; Nie D; Li Y; Pang Y; Fan Z; Li L; Jiang Z; Duan F; Li H; Zhang P; Gao Y; Ouyang L; Yue C; Xie M; Shi C; Xiao Y; Wang S
Bone Marrow Transplant; 2017 May; 52(5):704-710. PubMed ID: 28067873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
